openPR Logo
Press release

Drug Discovery Informatics Global Market By Mode, By Workflow, By Services, By Application, By End User, By Regional Forecast 2023-2032 | Certara, Infosys Ltd., PerkinElmer Inc., Oracle Corporation

04-26-2023 08:03 AM CET | IT, New Media & Software

Press release from: The Business research company

Drug Discovery Informatics Market

Drug Discovery Informatics Market

The Business Research Company's global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

Drug Discovery Informatics Market Size, Growth Rate, And Forecast
The global drug discovery informatics market size is expected to grow from $2.97 billion in 2022 to $3.32 billion in 2023 at a compound annual growth rate (CAGR) of 12.0%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global drug discovery informatics market size is expected to grow to $5.21 billion in 2027 at a CAGR of 11.9%.

Request For Free Sample Report - https://www.thebusinessresearchcompany.com/sample.aspx?id=8960&type=smp

Drug Discovery Informatics Market Drivers
The rising prevalence of various chronic diseases is expected to propel the growth of the drug discovery informatics market going forward. Chronic illnesses are described generically as disorders that persist for a year or longer and need continuing medical treatment, impede everyday activities or both.

Learn More On The Drug Discovery Informatics Market Report Here:
https://www.thebusinessresearchcompany.com/report/drug-discovery-informatics-global-market-report

Drug Discovery Informatics Market Segments
• By Service: In-House, Outsourced
• By Modality: Cloud-Based Systems, In-Campus
• By Application: Data Sequencing, Molecular Docking, Identification and Validation, Target Data Analysis
• By End-User: Pharmaceutical Companies, Contract Research Organizations, Bio-Technology Companies
• By Geography: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. North America was the largest region in the Drug discovery informatics market.

Check Out Buying Options For The Drug Discovery Informatics Market Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=8960

Drug Discovery Informatics Market Key Players
Major competitors in the Drug discovery informatics market include Certara, Charles River Laboratories Inc., Infosys Ltd., Collaborative Drug Discovery Inc., Eurofins DiscoverX Products, Jubilant Biosys, Selvita, PerkinElmer Inc., International Business Machines Corporation, Boehringer Ingelheim International GmbH, Oracle Corporation, Thermo Fisher Scientific Inc., Albany Molecular Research Inc., and ChemAxon Ltd.

The Business Research Company's "Global Drug Discovery Informatics Market Report 2023" is a comprehensive report of the market, covering over 60 geographies and high-level market segmentation per geography. The section on regional and country breakdowns examines the market in each geography as well as market size by region and country. Furthermore, it evaluates the market's historical and projected growth and identifies significant trends and strategies that businesses can use to expand their operations.

The Table of Content for The Drug Discovery Informatics Market Include:
1. Executive Summary
2. Drug Discovery Informatics Market Characteristics
3. Drug Discovery Informatics Market Trends And Strategies
4. Drug Discovery Informatics Market - Macro Economic Scenario
5. Drug Discovery Informatics Market Size And Growth
.....
26. Africa Drug Discovery Informatics Market
27. Drug Discovery Informatics Market Competitive Landscape And Company Profiles
28. Key Mergers And Acquisitions In The Drug Discovery Informatics Market
29. Drug Discovery Informatics Market Future Outlook and Potential Analysis
30. Appendix

Contact us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Latest Trending Press Releases: https://www.thebusinessresearchcompany.com/press-release.aspx

Want To Know More About The Business Research Company?
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialise in various industries including manufacturing, healthcare, financial services, chemicals, and technology.

Global Market Model - World's Most Comprehensive Database
The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Drug Discovery Informatics Global Market By Mode, By Workflow, By Services, By Application, By End User, By Regional Forecast 2023-2032 | Certara, Infosys Ltd., PerkinElmer Inc., Oracle Corporation here

News-ID: 3029957 • Views:

More Releases from The Business research company

Antiviral Combination Therapy Market Surges: Reaches $54.5 Billion in 2024, Set for $71.16 Billion in 2028, CAGR 6.9%
Antiviral Combination Therapy Market Surges: Reaches $54.5 Billion in 2024, Set …
The antiviral combination therapy market size has grown strongly in recent years. It will grow from $51.15 billion in 2023 to $54.5 billion in 2024 at a compound annual growth rate (CAGR) of 6.5%. The growth in the historic period can be attributed to risen viral infections, patient preference for combination treatments, emergence of drug resistance, advancements in virology and immunology, global healthcare initiatives. The antiviral combination therapy market size is
Aluminum Composite Panels Market on Upward Trajectory: Expected to Reach $8.83B in 2028, CAGR 7.4%, Propelled by Construction Demand
Aluminum Composite Panels Market on Upward Trajectory: Expected to Reach $8.83B …
The aluminum composite panels market size has grown strongly in recent years. It will grow from $6.13 billion in 2023 to $6.62 billion in 2024 at a compound annual growth rate (CAGR) of 8.0%. The growth in the historic period can be attributed to architectural growth and modern construction trends, increasing urbanization and infrastructure development, durability and weather resistance, versatility in design and aesthetic appeal, cost-effectiveness and material efficiency. The aluminum
Aircraft Fairings Market Set to Surge to $2.67 Billion by 2028 with 7.8% CAGR, Driven by Industry Growth and Innovation
Aircraft Fairings Market Set to Surge to $2.67 Billion by 2028 with 7.8% CAGR, D …
The aircraft fairings market size has grown strongly in recent years. It will grow from $1.82 billion in 2023 to $1.98 billion in 2024 at a compound annual growth rate (CAGR) of 9.0%. The growth in the historic period can be attributed to dairy industry growth, rotation crop benefits, rise of hay export market, biofuel and energy production, demand for organic feed. The aircraft fairings market size is expected to see
Bioactive Ingredients Market Top Players, Analysis, Strategies And Forecast 2033
Bioactive Ingredients Market Top Players, Analysis, Strategies And Forecast 2033
The bioactive ingredients market size has grown strongly in recent years. It will grow from $45.28 billion in 2023 to $48.8 billion in 2024 at a compound annual growth rate (CAGR) of 7.8%. The growth in the historic period can be attributed to health consciousness, rising incidence of chronic diseases, expanding aging population, increased demand for natural products, expansion of functional foods and beverages. The bioactive ingredients market size is

All 5 Releases


More Releases for Drug

Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions. Alcohol abuse and drug
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.  Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Introduction to Hepatitis Disease 1.1 Prologue 1.1.1 History of Hepatitis 1.1.2 Causes of Hepatitis Disease 1.2 Types of Viruses which are Responsible for Hepatitis Disease 2. Global Prevalence of Hepatitis Infection 3. Available Drug Classes for Hepatitis Disease Treatment 3.1 Interferon Alfa Therapy 3.2 Protease Inhibitors Therapy 3.3 Polymerase
Microcapsules Drug Delivery Market Microcapsules Drug Delivery Sales Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Indispensable Advent of Microcapsules 1.1 Trajectory of Microencapsulation 1.2 Why and wherefores for Microencapsulation 2. Characterization of Microcapsules 2.1 Composition of Microcapsules 2.2 Parameters Influencing Microcapsules 3. Engineering Technology of Microcapsules 3.1 Physical Manufacturing Technologies 3.2 Physicochemical and Chemical Technologies 4. Applicability of Microcapsules 4.1 Microcapsules in Pharmaceuticals 4.2 Microcapsules in Nutraceuticals
AstraZeneca’s NMOSD Drug receives orphan drug designation
April 18, 2017 Orphan Drug European Medicine Agency has Announced orphan drug designation for inebilizumab (earlier known as MEDI-551) developed by AstraZeneca PLC (AZN) for the treatment of neuromyelitis optica spectrum disorder (NMOSD). The drug has already received orphan drug status from US Food and Drug Administration (FDA). NMOSD, also called Devic’s disease, is a rare, autoimmune disorder of the central nervous system (CNS) that affects the functioning
Drug Discovery Strategies, PBPK Modeling and Drug-Drug Interaction Explored and …
This year’s 12th annual ADMET conference and exhibition promises to deliver appearances from experienced pharmaceutical professionals from ADME and PK/PD organisations such as AbbVie, GSK, Roche and Bayer when it returns to London this June. The carefully selected speaker line up will be addressing early ADME application strategies and discussing the latest technologically advanced screening and testing models along with exploring ADMET technologies which will identify properties of a drug